comorbidities for glp 1 Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review Weight Reduction with GLP-1 Agonists

Among women with PCOS, semaglutide or tirzepatide prescribing increased from 2.4% in 2021 to 17.6% in 2025, a more than 7-fold increase

You have seen the ads

This may shorten the telogen (rest) phase and encourage a quicker return to the anagen (growth) phase

Their stated mission is to "connect you with healthcare providers" to facilitate "access to qualified healthcare providers and wellness medications ." Here is a breakdown of the specific claims Brello makes regarding their service, process, and expected results: Access to GLP-1 Medications Brello claims to provide access specifically to Semaglutide and Tirzepatide